Alibaba (BABA) Pays $600 Million to Settle DOJ Drug Probe

Alibaba Group Holding (NYSE:BABA), the Chinese e-commerce giant behind Alibaba.com and AliExpress, has agreed to pay 600 million dollars alongside its U.S. payment affiliate AUS Merchant Services to settle Justice Department allegations tied to illegal pharmaceutical sales on its platforms. Shares fell 1.89 percent to 96.14 dollars on the news.

The non-prosecution agreements, announced Wednesday, resolve claims that Alibaba and AUS violated the Federal Food, Drug, and Cosmetic Act by allowing merchants to funnel illegal drugs, controlled substances, regulated chemicals and pill presses into the United States through Alibaba.com and AliExpress.com. Alibaba accepted responsibility for roughly 80,000 prohibited transactions between January 2016 and December 2024, with a combined gross merchandise value exceeding 200 million dollars. Federal agents reportedly made undercover purchases of banned pharmaceuticals and pill counterfeiting equipment on more than 40 occasions to build the case.

Compliance Failures and the Cost of the Settlement

Internal employees had apparently flagged concerns about whether Alibaba's safeguards were adequate, even while official policies barring restricted goods stayed in place. The company also ran a private messaging tool that some sellers used to coordinate illicit deals, occasionally steering buyers toward encrypted third party apps. On the payments side, AUS Merchant Services, a subsidiary of Ant Group formerly known as Alipay U.S., admitted that holes in its anti money laundering controls let certain merchants push prohibited transactions through its network. Wire transfer data reportedly was not always reaching the firm's monitoring systems, which meant suspicious activity from high risk regions went unnoticed. One seller, according to court records, kept sending banned goods to U.S. buyers even after AUS had already flagged the account.

Alibaba will pay 125 million dollars in criminal fines plus a 200 million dollar forfeiture, while AUS will contribute 85 million dollars in fines and 190 million dollars in forfeited funds. Both companies agreed to rebuild their compliance programs and keep working with prosecutors going forward.

Alibaba Valuation, Momentum and Yield

Alibaba's market capitalization stands at 230.70 billion dollars, and the stock trades well below its 52 week high of 146.87 dollars, sitting closer to the low end of a range that bottomed at 91.99 dollars. Its relative strength index of 24.03 signals the shares are deep in oversold territory, a level traders often watch for signs of exhaustion in a selloff. The dividend yield of 1.09 percent offers a modest cushion for holders while sentiment sorts itself out.

The bull case rests on the idea that a 600 million dollar settlement, while sizable, draws a line under a legal overhang that has weighed on the stock, and that Alibaba's core commerce and cloud businesses remain intact. Bears counter that the compliance failures described in the settlement, including gaps in monitoring and internal warnings that went unheeded for years, raise questions about oversight that could resurface in other jurisdictions. The stock's earnings per share and price to earnings multiple were not disclosed in the current data set, leaving investors to weigh the settlement's reputational cost against a valuation that already reflects plenty of skepticism.

What the Settlement Signals for Marketplace Oversight

Assistant Attorney General Brett A. Shumate said companies running online marketplaces, whether domestic or foreign, must put safeguards in place to keep bad actors from exploiting their platforms, warning that the department will hold firms accountable when they fall short. That message extends beyond Alibaba to any large marketplace operator handling cross border transactions, and it suggests regulators intend to keep scrutinizing how platforms police what moves through their systems, particularly when payment processors and marketplaces share corporate ties.